2-Pyrrolidone → 1,1'-(4-{[4-(3,5-Dimethylpyridin-2-yl)piperazin-1-yl]carbonyl}-1,3-phenylene)dipyrrolidin-2-one
反応式
Cl[C:2]1[CH:3]=[CH:4][C:5]([C:14]([N:16]2[CH2:21][CH2:20][N:19]([C:22]3[C:27]([CH3:28])=[CH:26][C:25]([CH3:29])=[CH:24][N:23]=3)[CH2:18][CH2:17]2)=[O:15])=[C:6]([N:8]2[CH2:12][CH2:11][CH2:10][C:9]2=[O:13])[CH:7]=1.[NH:30]1[CH2:34][CH2:33][CH2:32][C:31]1=[O:35]>>[CH3:28][C:27]1[C:22]([N:19]2[CH2:20][CH2:21][N:16]([C:14]([C:5]3[CH:4]=[CH:3][C:2]([N:30]4[CH2:34][CH2:33][CH2:32][C:31]4=[O:35])=[CH:7][C:6]=3[N:8]3[CH2:12][CH2:11][CH2:10][C:9]3=[O:13])=[O:15])[CH2:17][CH2:18]2)=[N:23][CH:24]=[C:25]([CH3:29])[CH:26]=1参加物
3
実験手順
Using 1-{5-chloro-2-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}pyrrolidin-2-one (206 mg) described in Preparation Example 169 and pyrrolidin-2-one (43 mg) and by the reaction and treatment in the same manner as in Example 352, the title compound (73 mg) was obtained.
出典と根拠
- ORDレコード
- ord-b608304ec9a643f0a6bc47ee351c1c1b